Skip to content
Use caution Drug recall · FDA · Published February 12, 2020

Golden State Medical Recalls Tramadol Tablets Due to Labeling Errors

Golden State Medical Supply recalls specific lots of 50 mg Tramadol tablets because the patient leaflets contain incorrect dosing instructions.

🇺🇸 FDA recall #D-0856-2020DrugGolden State Medical Supply ›
Take action

Contact the company

Recalling firmGolden State Medical Supply Inc.5187 Camino Ruiz · Camarillo, CA 93012-8601
✎ GovInfoNow plain-language explainer

Golden State Medical Supply Inc. is recalling unscored 50 mg Tramadol Hydrochloride Tablets because the included patient information leaflets incorrectly reference a 25 mg dosing titration that requires scored tablets. This labeling error could lead to confusion for patients who have been prescribed these specific unscored tablets. The recall affects lots distributed nationwide in the USA. Read more at govinfonow.com/recall/37375-golden-state-medical-recalls-tramadol-tablets-due-to-labeling-errors.

Source Summary by GovInfoNow · govinfonow.com/recall/37375-golden-state-medical-recalls-tramadol-tablets-due-to-labeling-errors · Updated October 11, 2026 · FDA enforcement record: FDA #D-0856-2020

Cite this page

“Golden State Medical Recalls Tramadol Tablets Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37375-golden-state-medical-recalls-tramadol-tablets-due-to-labeling-errors. Based on FDA recall #D-0856-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0856-2020%22&limit=1).

The FDA announced on Feb. 12, 2020, that Golden State Medical Supply Inc. voluntarily recalled Tramadol Hydrochloride Tablets due to incorrect labeling in the patient leaflets. The agency stated the recall was initiated by the firm.

How to tell if you have it

  • Brand: Golden State Medical Supply
  • Product: TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only
  • Packaging: 100-count bottles (NDC 60429-588-01) and 500-count bottles (NDC 60429-588-05)
  • Lot Numbers: GS021259, GS021742, GS022074, GS022619, GS022836, GS023243, GS023631, GS023869, GS024562, GS025492, GS025184, GS026306, GS026654, GS027566, GS028574 (100-ct); GS021570, GS021444, GS021445, GS021443, GS021447, GS021446, GS021745, GS021746, GS021744, GS022076, GS022077, GS022078, GS022075, GS021747, GS021748, GS022622, GS022623, GS022624, GS022620, GS022837, GS022838, GS022856, GS022621, GS023029, GS023028, GS023027, GS023958, GS023959, GS023960, GS025045, GS024929, GS025048, GS025047, GS025588, GS025046, GS025260, GS025259, GS025717, GS025719, GS025718, GS023607, GS026308, GS026309, GS026912, GS026911, GS026910, GS027678, GS027836, GS027570, GS027569, GS027572, GS027571 (500-ct)
  • Distribution: Nationwide in the USA

The hazard

The patient leaflets for the specified lots contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet. The tablets recalled are unscored.

Context

GovInfoNow's records show Golden State Medical Supply Inc. has 31 other recalls on record since April 14, 2014. Other recent recalls include Golden State Medical Recall of Prasugrel HCl 10mg Tablets on Aug. 21, 2026, and Golden State Medical Supply recall of Carbamazepine 200mg tablets on Aug. 7, 2026. Other recent recalls of similar products include Greenstone Methylprednisolone Tablets Recall on Jan. 15, 2026, and Amneal traMADol 50mg Tablets Recall on March 19, 2026.

How to tell if you have this one

Check your medication bottle for NDC numbers 60429-588-01 (100-count bottles) or 60429-588-05 (500-count bottles). Verify the lot numbers against the list provided in the record, such as GS021259, GS021742, or GS021570. The tablets are unscored 50 mg Tramadol Hydrochloride Tablets, USP.

  • Brand
    Golden State Medical Supply
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your Tramadol bottle matches the NDC numbers and lot numbers listed in the recall record.

  2. Contact Your Pharmacist

    If you have an affected product, speak with your pharmacist or healthcare provider about how to proceed with your treatment.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.1 years after the firm started it.

1. Firm started the recall: Feb 12, 202012. FDA classified it Class III: Feb 26, 202023. Published in FDA’s Enforcement Report: Mar 4, 202034. FDA terminated the recall: Apr 4, 2023420202023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are affected?

Affected lots include GS021259, GS021742, GS022074, GS022619, GS022836, GS023243, GS023631, GS023869, GS024562, GS025492, GS025184, GS026306, GS026654, GS027566, GS028574 for 100-count bottles, and multiple lots starting with GS021570, GS021745, GS022622, etc., for 500-count bottles.

Similar recalls

Other Golden State Medical Supply recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0856-2020 (February 12, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0856-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA